CORD-19:35349bb1fc9290338907b7d7f104c9db3951163b / 147890-148230 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/35349bb1fc9290338907b7d7f104c9db3951163b","sourcedb":"CORD-19","sourceid":"35349bb1fc9290338907b7d7f104c9db3951163b","text":"Despite studies demonstrating that lower doses of toceranib (2.4 -2.9 mg/kg every other day) provides drug exposure sufficient for target inhibition while reducing the frequency of drug-related adverse events, gastrointestinal (GI) toxicity continues to be the most commonly encountered side effect in dogs receiving toceranib at this dose.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1098","span":{"begin":0,"end":340},"obj":"Sentence"},{"id":"T12936","span":{"begin":0,"end":340},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T1098","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T12936","pred":"source","obj":"CORD-19-Sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#a293ec","default":true}]}]}}